Nano Bio To Start Human Studies On Flu Vaccine
ANN ARBOR - NanoBio Corporation announced that data from its ferret influenza vaccine study of NB-1008 have been published in the July 2011 issue of "Clinical Vaccine Immunology" by the American Society of Microbiology. Data generated from the study demonstrate the robust antigen-sparing properties of NB-1008 and provided the necessary validation to move immediately into